Gut-Lung Microbiota Characterization in Patients with Non-Small Cell Lung Carcinoma and COVID-19 Coinfection
CONCLUSION: Eventually, it was found that compared to control groups, COVID-19 patients with NSCLC showed diminished gut bacteria diversity and increase in Lactobacillus spp., A. muciniphila, and Bifidobacterium spp. The overgrowth of Enterococcus spp., Streptococcus spp., and Prevotella spp. could be potential predictive biomarkers in the gut-lung axis of NSCLC patients with COVID-19.PMID:38619029 | DOI:10.34172/aim.2024.11
Source: Archives of Iranian Medicine - Category: Middle East Health Authors: Bahareh Vakili Parisa Shoaei Kiana Shahzamani Seyed Davar Siadat Hasan Shojaei Zahra Esfandiari Elahe Nasri Shiva Shabani Ali Zamani Moghadam Behrooz Ataei Source Type: research
More News: Cancer | Cancer & Oncology | Carcinoma | COVID-19 | Enterococcus | Iran Health | Lung Cancer | Middle East Health | Nasopharyngeal Cancer | Non-Small Cell Lung Cancer | Respiratory Medicine | Staphylococcus Aureus | Study